Beyond Medical Technologies (CSE: DOCT) (Frankfurt: 7FM2), is pleased to announce that it has entered into a letter of intent with Kayan Health Limited which sets out the basic terms and conditions for the acquisition by the Company of all the issued and outstanding securities of Kayan Health in exchange for securities of the Company.
Beyond Medical Technologies (“Beyond Medical” or the “Company”) (CSE: DOCT) (Frankfurt: 7FM2), is pleased to announce that it has entered into a letter of intent (the “Letter of Intent”) with Kayan Health Limited (“Kayan Health”) which sets out the basic terms and conditions for the acquisition by the Company of all the issued and outstanding securities of Kayan Health in exchange for securities of the Company (the “Transaction”). Following completion of the Transaction, Kayan Health will become a wholly-owned subsidiary of the Company.